vancomycin has been researched along with forapin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
| Gong, L; Jiang, Y; Li, B; Liu, H; Qiu, S; Tan, H; Yuan, Y; Zhao, L | 1 |
| Bie, X; Gao, L; Han, J; Liu, H; Lu, Z; Ma, Z; Yang, J; Zhao, H | 1 |
| Huo, L; Liu, H; Qiu, SX; Tan, H; Wang, M; Xu, Z; Yang, B; Zhang, W; Zhao, L | 1 |
| Dou, X; Feng, X; He, S; Shan, A; Song, J; Wang, J; Yang, Y; Yang, Z | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Ke, CQ; Li, BL; Qiu, SX; Tang, C; Wu, JW; Ye, Y; Zhu, NL | 1 |
| Demchenko, A; Demchenko, S; Elliott, AG; Fedchenkova, Y; Lesyk, R; Suvorova, Z; Zuegg, J | 1 |
| Gou, S; Ni, J; Xie, J; Yao, J; Zhang, F; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Grant, G; Patel, B; Rudrawar, S; Zunk, M | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Dewangan, RP; Ghosh, JK; Gupta, A; Habib, S; Mitra, K; Pant, G; Verma, DP; Verma, NK | 1 |
| Bourguet-Kondracki, ML; Cadelis, MM; Copp, BR; Deed, RC; Douafer, H; Li, SA; Michel Brunel, J | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
14 other study(ies) available for vancomycin and forapin
| Article | Year |
|---|---|
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Structure-activity relationships and optimization of acyclic acylphloroglucinol analogues as novel antimicrobial agents.
Topics: Acylation; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Phloroglucinol; RAW 264.7 Cells; Staphylococcal Infections; Structure-Activity Relationship | 2017 |
Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical Peptide Amphiphiles.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Bacteria; Cell Cycle; Cell Membrane Permeability; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptides; Protein Engineering; Structure-Activity Relationship; Surface-Active Agents | 2016 |
Structural optimization and antibacterial evaluation of rhodomyrtosone B analogues against MRSA strains.
Topics: | 2018 |
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biocompatible Materials; Gram-Negative Bacteria; HEK293 Cells; Humans; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Proteolysis; RAW 264.7 Cells; Spectrometry, Fluorescence | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Callistemonols A and B, Potent Antimicrobial Acylphloroglucinol Derivatives with Unusual Carbon Skeletons from
Topics: Anti-Bacterial Agents; Carbon; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Myrtaceae; Phloroglucinol; Plant Leaves; Spectrum Analysis | 2019 |
Synthesis, antibacterial and antifungal activity of new 3-biphenyl-3H-Imidazo[1,2-a]azepin-1-ium bromides.
Topics: Anti-Bacterial Agents; Antifungal Agents; Azepines; Bacteria; Fungi; HEK293 Cells; Hemolysis; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2020 |
Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Thiazoles | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Escherichia coli; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proline; Spermine; Staphylococcus aureus | 2022 |
Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
Topics: Abietanes; Adjuvants, Pharmaceutic; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Escherichia coli; Mammals; Microbial Sensitivity Tests; Polyamines; Structure-Activity Relationship | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |